Fungal Infections and Colonization after Bilateral Lung Transplant: A Six-Year Single-Center Experience

Annalisa Boscolo1,2,3, Annamaria Cattelan4, Serena Marinello4

  • 1Department of Medicine, University of Padua, 35122 Padua, Italy.

Insights

Fungal infections (FIs) occurred in 8% of lung transplant recipients (LTRs) within one year, with 23% experiencing colonization, primarily by Aspergillus. No specific risk factors or differences in outcomes were found between prophylactic strategies.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Transplant Surgery

Background:

  • Fungal infections (FIs) are a significant cause of morbidity and mortality in lung transplant recipients (LTRs) within the first year post-transplant.
  • Early detection and treatment of FIs are critical for improving LTR outcomes.
  • Aspergillus species are a common cause of fungal colonization in this patient population.

Purpose of the Study:

  • To assess the incidence of FIs and fungal colonization in the first year after bilateral lung transplantation.
  • To identify risk factors associated with FIs and colonization.
  • To compare fungal incidence across different prophylactic antifungal strategies.

Main Methods:

  • Retrospective screening of bilateral LTRs at Padua University Hospital.
  • Exclusion criteria included age <18, re-transplantation, and pre-LT mechanical support.
  • Analysis of 157 LTRs to determine FI and colonization rates and associated factors.

Main Results:

  • Overall incidence of FIs was 8% (13 patients) and fungal colonization was 23% (36 patients).
  • Aspergillus spp. was the predominant organism identified in colonization cases.
  • No independent risk factors for FIs were identified, and no significant differences in FI or colonization rates were observed between groups receiving different prophylactic strategies.

Conclusions:

  • The study found an 8% incidence of FIs and 23% incidence of fungal colonization in the first year post-bilateral lung transplant.
  • No significant predisposing factors or differences in outcomes related to antifungal prophylaxis strategies were identified.
  • Larger studies are warranted to validate these findings and further investigate risk factors and optimal prophylactic measures.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239